GUNN & Co INVESTMENT MANAGEMENT INC. Has $51.43 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

GUNN & Co INVESTMENT MANAGEMENT INC. increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1,337.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 97,679 shares of the healthcare conglomerate’s stock after buying an additional 90,883 shares during the period. UnitedHealth Group accounts for approximately 3.4% of GUNN & Co INVESTMENT MANAGEMENT INC.’s holdings, making the stock its 8th biggest holding. GUNN & Co INVESTMENT MANAGEMENT INC.’s holdings in UnitedHealth Group were worth $51,425,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. North Star Asset Management Inc. boosted its holdings in UnitedHealth Group by 4.3% in the fourth quarter. North Star Asset Management Inc. now owns 16,346 shares of the healthcare conglomerate’s stock valued at $8,606,000 after acquiring an additional 667 shares during the last quarter. MCF Advisors LLC lifted its holdings in UnitedHealth Group by 2.2% in the fourth quarter. MCF Advisors LLC now owns 2,582 shares of the healthcare conglomerate’s stock valued at $1,359,000 after buying an additional 55 shares during the period. OLD National Bancorp IN grew its holdings in UnitedHealth Group by 0.9% during the 4th quarter. OLD National Bancorp IN now owns 53,191 shares of the healthcare conglomerate’s stock worth $28,003,000 after acquiring an additional 473 shares during the period. Brendel Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $1,669,000. Finally, Commerzbank Aktiengesellschaft FI grew its stake in shares of UnitedHealth Group by 20.9% during the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 77,713 shares of the healthcare conglomerate’s stock worth $40,914,000 after purchasing an additional 13,458 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently commented on UNH shares. Stephens reaffirmed an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday, April 17th. Truist Financial reiterated a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Morgan Stanley dropped their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. Finally, StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Stock Down 0.1 %

NYSE:UNH opened at $492.45 on Friday. The firm has a market capitalization of $453.09 billion, a price-to-earnings ratio of 30.10, a price-to-earnings-growth ratio of 1.43 and a beta of 0.55. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The stock’s 50 day moving average price is $482.32 and its two-hundred day moving average price is $512.76.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the previous year, the business earned $6.26 earnings per share. The business’s revenue was up 8.6% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.53%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.